clinical trials

June 25, 2015
· Diana Chingos

My Four Takeaways from the 2015 ASCO Annual Meeting

diana.chingos

Patient advocate Diana Chingos wanted to attend the 2015 ASCO Annual Meeting to learn about the latest cancer research. After four intense days of posters and presentations, she left Chicago with a mountain of new knowledge and four key insights.

Read More >>
June 4, 2015
· Cat Snyder, ASCO staff

Expert Conversations: Bladder Cancer

catherine.snyder

In this podcast, experts Charles Ryan, MD, and Thomas Powles, MD, talk about bladder cancer treatment, including some of the new approaches that are being developed.

Read More >>
June 2, 2015
· Amber Bauer, ASCO staff

Progress through Cancer Research: Helping People Live Longer, Better Lives

amber.bauer

Two out of three people now live at least five years after being diagnosed with cancer, but there is still more to be done. Researchers at the 2015 ASCO Annual Meeting showed how new treatment options can continue to improve and lengthen the lives of people with both rare and common cancers.

Read More >>
May 30, 2015
· Amber Bauer, ASCO staff

A Targeted Approach to Treatment: Research from the 2015 ASCO Annual Meeting

amber.bauer

This year, President Obama has focused attention on treatments and tools that help doctors tailor medical care for individual patients. Research presented at the 2015 ASCO Annual Meeting shows how targeted therapies can be used to improve the care of people with a number of different types of blood cancer.

Read More >>
April 28, 2015
· Cat Snyder, ASCO staff

FDA Approval of Nivolumab for Lung Cancer

catherine.snyder

Dr. Julie Brahmer from the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins shares details about the recent FDA approval of nivolumab (Opdivo) for advanced non-small cell lung cancer. She explains how this impacts the treatment of lung cancer.

Read More >>

Pages

Subscribe to RSS - clinical trials